Fresenius Medical Care AG & Co. KGaA - FMS Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care AG & Co. KGaA in the last twelve months. There are currently 3 sell ratings, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View FMS analyst ratings or view top-rated stocks.

9 equities research analysts have issued twelve-month price objectives for Fresenius Medical Care AG & Co. KGaA's stock. Their FMS share price forecasts range from $11.70 to $72.00. On average, they anticipate the company's stock price to reach $35.96 in the next year. This suggests a possible upside of 82.2% from the stock's current price.
View analysts price targets for FMS or view top-rated stocks among Wall Street analysts.

Fresenius Medical Care AG & Co. KGaA's stock was trading at $16.34 on January 1st, 2023. Since then, FMS stock has increased by 20.8% and is now trading at $19.74.
View the best growth stocks for 2023 here.

Fresenius Medical Care AG & Co. KGaA saw a increase in short interest in the month of December. As of December 30th, there was short interest totaling 1,280,000 shares, an increase of 14.3% from the December 15th total of 1,120,000 shares. Based on an average trading volume of 1,190,000 shares, the short-interest ratio is presently 1.1 days.
View Fresenius Medical Care AG & Co. KGaA's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023.
View our FMS earnings forecast.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) announced its quarterly earnings results on Tuesday, November, 2nd. The company reported $0.55 earnings per share for the quarter, hitting the consensus estimate of $0.55. The company earned $5.24 billion during the quarter, compared to analysts' expectations of $5.37 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.01% and a trailing twelve-month return on equity of 6.03%.

Fresenius Medical Care AG & Co. KGaA declared an annual dividend on Friday, April 29th. Stockholders of record on Monday, May 16th will be paid a dividend of $0.7093 per share on Friday, May 27th. This represents a dividend yield of 3.4%. The ex-dividend date is Friday, May 13th.
Read our dividend analysis for FMS.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) pays an annual dividend of $0.49 per share and currently has a dividend yield of 2.58%. The dividend payout ratio is 34.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 42.61% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care AG & Co. KGaA investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).

Fresenius Medical Care AG & Co. KGaA trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

Fresenius Medical Care AG & Co. KGaA's stock is owned by a variety of institutional and retail investors. Top institutional investors include Pzena Investment Management LLC (4.15%), Pacer Advisors Inc. (0.02%), Capricorn Fund Managers Ltd (0.02%), Crossmark Global Holdings Inc. (0.01%), First Heartland Consultants Inc. (0.01%) and Hardman Johnston Global Advisors LLC (0.01%).

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of FMS stock can currently be purchased for approximately $19.74.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has a market capitalization of $11.57 billion and generates $20.85 billion in revenue each year. The company earns $1.15 billion in net income (profit) each year or $1.41 on an earnings per share basis.

The company employs 122,909 workers across the globe.

Fresenius Medical Care AG & Co. KGaA's mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The official website for the company is www.freseniusmedicalcare.com. The company can be reached via phone at (496) 172-6090, via email at ir@fmc-ag.com, or via fax at 49-6172-609-2301.